文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

ATN与RENAL试验中肾脏替代治疗模式及治疗方案对肾脏结局的影响

Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials.
PubMed 文献 · Crit Care · 2022-09-06
一句话结论在ATN与RENAL试验的危重急性肾损伤患者中,初始CRRT与IHD相比28天RRT依赖无差异,但在幸存者中初始IHD与ATN方案与28天RRT依赖风险升高相关。

该研究基于ATN与RENAL两项试验的2542例危重急性肾损伤患者,比较初始肾脏替代治疗模式(CRRT vs IHD)及治疗方案对28天RRT依赖的影响。校正混杂因素后,初始CRRT与IHD的28天RRT依赖无差异(SHR 0.96,95%CI 0.84-1.10;p=0.570),住院死亡率亦无差异(OR 1.14,95%CI 0.86-1.52;p=0.361)。但在幸存者中,初始CRRT与28天RRT依赖降低相关(OR 0.54,95%CI 0.37-0.80;p=0.002),且无RRT天数更多(common OR 1.38,95%CI 1.11-1.71)。在初始CRRT患者中,ATN治疗方案与无RRT天数更少、死亡率更高及28天RRT依赖增加四倍相关。

要点

  • 在2542例危重AKI患者中,初始CRRT与IHD相比,28天RRT依赖无差异(SHR 0.96,95%CI 0.84-1.10;p=0.570),住院死亡率亦无差异(OR 1.14,95%CI 0.86-1.52;p=0.361)。
  • 在幸存者中,初始CRRT与28天RRT依赖降低相关(OR 0.54,95%CI 0.37-0.80;p=0.002),且无RRT天数更多(common OR 1.38,95%CI 1.11-1.71)。
  • 在初始CRRT患者中,ATN治疗方案与无RRT天数更少、死亡率更高及28天RRT依赖增加四倍相关。
  • 初始CRRT患者病情更重,但校正后28天RRT依赖无组间差异。

适用人群与场景

  • 危重急性肾损伤患者,来自ATN与RENAL两项随机试验,共2542例。
  • 初始肾脏替代治疗模式为CRRT(2175例,85.5%)或IHD(367例,14.4%)。

研究设计与关键结果

  • 研究类型:基于ATN与RENAL两项随机试验的二次分析;样本量2542例;人群为危重急性肾损伤患者。
  • 主要终点:28天RRT依赖,初始CRRT与IHD相比无差异(SHR 0.96,95%CI 0.84-1.10;p=0.570)。
  • 住院死亡率:初始CRRT与IHD相比无差异(OR 1.14,95%CI 0.86-1.52;p=0.361)。
  • 幸存者中,初始CRRT与28天RRT依赖降低相关(OR 0.54,95%CI 0.37-0.80;p=0.002),且无RRT天数更多(common OR 1.38,95%CI 1.11-1.71)。
  • 在初始CRRT患者中,ATN治疗方案与无RRT天数更少、死亡率更高及28天RRT依赖增加四倍相关。

证据类型、等级与局限

  • 证据类型:基于两项随机试验的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在幸存者中,初始IHD与ATN治疗方案均与28天RRT依赖风险升高强烈相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In critically ill patients with acute kidney injury, renal replacement therapy (RRT) modality and treatment protocols may affect kidney recovery. This study explored whether RRT modality and treatment protocol affected RRT dependence in the 'Randomized Evaluation of Normal versus Augmented Level of RRT' and the 'Acute Renal Failure Trial Network' (ATN) trials.

METHODS: Primary outcome was 28-day RRT dependence. Secondary outcomes included RRT dependence among survivors and in different SOFA-based treatment protocol groups. We used the Fine-Gray competing-risk model sub-distribution hazard ratio (SHR) to assess the primary outcome. Analyses were adjusted for confounders.

RESULTS: Of 2542 patients, 2175 (85.5%) received continuous RRT (CRRT) and 367 (14.4%) received intermittent hemodialysis (IHD) as first RRT modality. CRRT-first patients had greater illness severity. After adjustment, there was no between-group difference in 28-day RRT dependence (SHR, 0.96 [95% CI 0.84-1.10]; p = 0.570) or hospital mortality (odds ratio [OR], 1.14 [95% CI 0.86-1.52]; p = 0.361) However, among survivors, CRRT-first was associated with decreased 28-day RRT dependence (OR, 0.54 [95% CI 0.37-0.80]; p = 0.002) and more RRT-free days (common OR: 1.38 [95% CI 1.11-1.71]). Moreover, among CRRT-first patient, the ATN treatment protocol was associated with fewer RRT-free days, greater mortality, and a fourfold increase in RRT dependence at day 28.

CONCLUSIONS: There was no difference in RRT dependence at day 28 between IHD and CRRT. However, among survivors and after adjustment, both IHD-first and the ATN treatment protocol were strongly associated with greater risk of RRT dependence at 28 days after randomization. Trial registration NCT00221013 registered September 22, 2005, and NCT00076219 registered January 19, 2004.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Naorungroj T, Neto AS, Wang A, et al. Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials. Crit Care. 2022. PMID: 36068554. doi:10.1186/s13054-022-04151-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。